News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Raffaele Colombo: Sacituzumab tirumotecan was approved for a second indication by NMPA in China
Raffaele Colombo/LinkedIn
Mar 11, 2025, 09:56

Raffaele Colombo: Sacituzumab tirumotecan was approved for a second indication by NMPA in China

Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared a post on X:

“Sacituzumab tirumotecan approved for a second indication by NMPA in China:

for the treatment of adult patients with EGFR-mutant locally advanced or metastatic non-squamous NSCLC following progression on EGFR-tyrosine kinase inhibitor therapy and platinum-based chemotherapy.”

Raffaele Colombo

cancer OncoDaily Oncology Raffaele Colombo Sacituzumab Tirumotecan
Special Coverage
Blog
Jun 17, 2025, 12:04
Shehryar Nasir Khawaja: Looking Forward to Presenting Our Work On Postoperative Pain in Head and Neck Cancer Survivors at MASCC 2025
Blog
Jun 17, 2025, 11:38
Erman Akkus: Phase 1 Dual‐dose Escalation Study of Radiation and Nab‐paclitaxel in Pancreatic Cancer
Insight
Jun 17, 2025, 11:22
Dipesh Uprety Highlighted Phase 3 IMforte trial on First-line Maintenance Therapy With Lurbinectedin Plus Atezolizumab in SCLC
Blog
Jun 17, 2025, 11:08
New Funding Opportunity: Quality Improvement Grant Funding From Conquer Cancer's EveryGrant and Pfizer
Opinion
Jun 17, 2025, 10:50
Mark Lewis: New MEN1 Guidelines - My Personal Perspective As a Patient, Parent, and Physician
Insight
Jun 17, 2025, 10:46
LuCE President Debra Montague Will Speak at the First-ever EU Cancer Mission Conference in Warsaw
Blog
Jun 17, 2025, 10:34
Amer Zeidan: Long Awaited Results of VERONA in Higher Risk MDS
Blog
Jun 17, 2025, 10:12
Equity, Diversity and Inclusion in Cancer Care Stakeholder Forum Kicked off in Brussels - Youth Cancer Europe
Blog
Jun 17, 2025, 10:05
Luis E Raez: The New Memorial HealthCare System Campaign
Insight
Jun 17, 2025, 09:59
Mark Wildgust: Outstanding Results from the FLAIR Study Presented at EHA25
Blog
Jun 17, 2025, 09:57
Anna Sureda: Excellent EHA-EBMT Joint Session at EHA 2025 in Milan
Blog
Jun 17, 2025, 09:56
Yan Leyfman: Great Presentation about the Promise of Armored CAR T cells without Lymphodepletion Therapy